Ohio U.S. Senate Candidate Vance Slams FDA for ‘Racialized’ COVID Therapeutic Distribution

JD Vance

Ohio U.S. Senate candidate J.D. Vance spoke with The Ohio Star Monday about anti-white discrimination in monoclonal antibody treatment for patients with COVID-19.

“You should not, in this country, have your fortune determined by your skin color,” he told The Star, noting the irony of having the discussion on Martin Luther King Jr. day. “It’s a fundamental principle of our Republic that we should not punish or reward people based on skin color, but we’re doing that right now.”

Read the full story

DeSantis Pushes for More Monoclonal Treatments from Federal Government

Florida Gov. Ron DeSantis

At a press conference yesterday, Florida Gov. Ron DeSantis (R) called for more monoclonal treatments to be sent to Florida from the federal government. DeSantis said the vaccine is not preventing COVID transmission like they were marketed to do.

The most recent variant spike, omicron, is the least severe variant of COVID and shows characteristics no more deadly than the common cold.

Read the full story

Florida Gov. DeSantis Announces New Preventative Monoclonal Treatment for Immunocompromised

Yesterday, Florida Gov. Ron DeSantis (R) announced a new preventative monoclonal treatment will be available for immunocompromised Floridians like cancer patients and transplant recipients. DeSantis said the new product from AstraZeneca, a pre-exposure prophylactic called Evusheld, is the newest development in Florida’s fight against COVID.

Read the full story

Florida’s COVID Numbers Continue to Decline, Reports Lowest Daily Cases per Capita in U.S.

Florida’s positive coronavirus cases have continued to decline over recent weeks, allowing the state to report the lowest number of cases per capita in the country.

According to data compiled by The New York Times, the state has an average of 1,393 cases per day, as of Friday. The average represents approximately six cases per 100,000.

Read the full story

Representative Diana Harshbarger Introduces Legislation That Would Lift Federal Control of Monoclonal Antibody Treatment

Tennessee Representative Diana Harshbarger (R-TN-01) and 17 of her fellow representatives introduced the Treatment Restoration for Emergency Antibody Therapeutics (TREAT) Act, according to a Thursday press release.

The congress member’s statement notes the measure intends to end President Biden’s Department of Health and Human Services (HHS) policy that limits access to monoclonal antibody (mAb) treatments for the treatments of COVID-19.

Read the full story

Feds Trim Florida’s Monoclonal Antibody Allotment After State Fueled National Surge in Demand

Florida Gov. Ron DeSantis has spent two months cross-crossing the state promoting sites and clinics that offer monoclonal antibody treatments, an increasingly popular alternative to vaccines for protection from COVID-19.

In fact, so popular that last week, the U.S. Department of Health & Human Services (DHS), while increasing overall supplies by 50%, from 100,000 to 150,000 doses a week nationwide, but capping the number of doses being delivered to Florida and six other Southern states that had previously consumed more than 70% of the nation’s monoclonal antibody treatments.

Read the full story

States Prepare for Limits on Key COVID Treatment, Criticize Federal Rationing

Gov Ron SeSantis

Demand for a key COVID-19 treatment has led to a nationwide shortage, and as President Joe Biden’s administration rations how much each state receives, some governors are pushing back over having to decide how to use their limited supplies.

Many states are warning their residents that the treatment may not be available, and some are discussing offering it only to unvaccinated individuals. On Tuesday, Kentucky Gov. Andy Beshear, a Democrat, warned his states’ residents that there is “not going to be enough” of the treatment.

Read the full story

Tampa General Hospital CEO Highly Critical of Biden’s Monoclonal Rations

Tampa General Hospical

The CEO of Tampa General Hospital has gone on the offensive, criticizing the President Joe Biden administration’s decision to ration monoclonal antibody treatments to states like Florida. The Department of Health and Humans Services (HHS) announced they will be handling the nationwide distribution of the treatments, earning much criticism from Florida officials who have been implementing the treatment for months.

Read the full story

Florida Gov. DeSantis Says Monoclonal Antibody Treatment Has Decreased COVID-19 Hospitalizations

Governor DeSantis announced Thursday that the 21 monoclonal antibody treatment centers he issued last month have positively resulted in a decrease in the number of hospitalizations in Florida that surged due to the COVID-19 delta variant.

Data from the Florida Hospital Association from Wednesday showed that 14,682 people were hospitalized with COVID-19 on Tuesday – a decrease of 9.9% in the last seven days.

Read the full story

Regeneron’s Monoclonal Antibody Treatment in Florida Is Having Positive Impact

In Jacksonville and Ocala, Regeneron’s monoclonal antibody treatment sites are seeing hundreds of people receive the therapy, and it is proving successful in its early treatment phase.

Florida Gov. Ron DeSantis has been pushing for the use of the treatment for COVID patients early in their infection. The design is to receive the monoclonal treatment before serious symptoms kick in.

Read the full story

Governor DeSantis Supports Monoclonal Antibody Treatment for High-Risk COVID Patients

Governor DeSantis expressed his support for Regeneron’s monoclonal antibody treatment Thursday, as COVID cases and the number of hospitalizations continue to surge in Florida.

According to DeSantis, “These treatments have been proven successful, with clinical trials resulting in a 70% reduction in hospitalization and death for COVID patients,” especially those who have higher risk for severe complications due to age or preexisting medical conditions.

As reported by the Food and Drug Administration (FDA), “Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens such as viruses.” The treatment is meant for individuals who have tested positive or recovered from COVID.

Read the full story